Bing

SEARCH HISTORY

While this is a cheap way to go public, it means there is no investment banker coverage to support the stock. Also, shortly after it came public it was the subject of a paid promotion campaign that briefly spiked the stock. A Seeking Alpha article at the ...
Seeking Alpha · 6/26/2015
Baxter International (NYSE:BAX) has opened bearishly below the pivot of $72.15 today ... or 5.3% below the average consensus analyst price target of $75.40. The stock should discover initial support at its 200-day moving average (MA) of $70.32 and ...
Financial News Network Online · ByPeter Chu · 1 day ago
Long puts lock in the price where a stock can be sold no matter how far it might drop ... (See our Education section) BAX is up 1.32 percent to $71.60 after closing above its 200-day moving average yesterday for the first time since the beginning of ...
Yahoo Finance · 6/24/2015
More from Bing News
Baxter expects "when-issued" trading for both Baxter and Baxalta to begin on the NYSE on June 15, 2015 under the symbol "BAX WI" for Baxter and "BXLT WI" for Baxalta. Holders of Baxter common stock are encouraged to consult with their financial …
4 Traders · 6/17/2015
[Business Wire] – Baxter International Inc. , announced today that its board of directors has approved the planned separation of its biopharmaceuticals business, which will be known as Baxalta Incorporated, and declared a special dividend distribution of ...
Jutia Group · 6/5/2015
What is the latest on injured recruit Dre'Mont Jones and how hard it is it to see a football star get hurt on the hardwood? Is there a rising star in coaching with Buckeyes ties that Bucknutters should be keeping an eye? Is the NFL's Scouting Combine next ...
247 Sports · 3/8/2015
Baxter Reports Record Sales, Earnings and Cash Flow for Full-Year 2012 Increased Investments in R&D and Business Development Set Strong... BAXTER DELIVERS SOLID FINANCIAL PERFORMANCE IN LINE WITH GUIDANCE FOR THIRD QUARTER …
Stockhouse · 6/23/2015
2015 under the symbol “BAX WI” for Baxter and “BXLT WI” for Baxalta. Holders of Baxter common stock are encouraged to consult with their financial advisor regarding the specific implications of selling Baxter common stock on or before the ...
Market Watch · 6/5/2015
After doubling in price in just three months, shares of TrovaGene Inc. (Nasdaq: TROV) – the San Diego-based “liquid-biopsy” play we first recommended back on March 11 – have sold off sharply in the past week. That’s not a surprise. In our initial ...
Money Morning · 3/28/2014
FNRG requested that a regulatory agency review the trading activity in its common stock subsequent to the issuance of a lengthy ... After the closing bell on Friday, BAX said that the Phase III clinical trial of BAX 111 met its primary efficacy endpoint ...
Smallcap Network · 4/18/2015

Baxter International

Company
Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to tr…
Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company had 2013 sales of $15.3 billion, across two businesses: BioScience and Medical Products. Baxter’s BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine; and vaccines. Baxter’s Medical Products business produces intravenous solutions and other products used in the delivery of fluids and drugs to patients; inhalation anesthetics; contract manufacturing services; and products to …
Data from: Wikipedia